HEART Pathway Calculator – Emergency Department Chest Pain Assessment

Clinical calculation support · Verify results before clinical use

Emergency Department Chest Pain Assessment

Calculate the HEART score and assess serial troponin results using a structured pathway.

—HEART Score

1. Clinical assessment

Select the clinical category that best represents the patient's presentation. History scoring requires clinician judgement.

Use the ECG interpretation relevant to the current presentation.
<45 years = 0; 45–64 years = 1; ≥65 years = 2.
Count hypertension, hypercholesterolemia, diabetes, obesity, smoking, and family history of premature CAD.
Known atherosclerotic disease is scored as 2 points in the HEART risk-factor component. The separate known-CAD flag is an additional conservative pathway eligibility check; it does not add another score point.

2. Initial cardiac troponin

Enter the initial troponin result and the assay-specific 99th percentile upper reference limit (URL), using the same units.

Use the laboratory's validated assay-specific limit and units.
This calculator does not create a universal hs-cTn delta threshold. For hs-cTn, the local assay-specific protocol must be applied and confirmed by the treating clinician. Conventional cTn serial sampling generally uses a 3–6-hour interval; hs-cTn serial sampling generally uses a 1–3-hour interval, subject to the validated local protocol.
—HEART
HEART score category
—
Pathway assessment

ComponentFindingPoints

About the HEART Pathway

The HEART score is a clinical risk-stratification instrument for adults presenting to the emergency department with symptoms suggestive of acute coronary syndrome (ACS). It evaluates History, ECG, Age, Risk factors, and Troponin, with each component contributing 0–2 points (total 0–10).

The HEART Pathway combines clinical risk assessment with serial cardiac troponin testing. A low HEART score alone is not equivalent to a completed low-risk pathway assessment.

HEART score components

ComponentCriteriaPoints
HistorySlightly / moderately / highly suspicious0 / 1 / 2
ECGNormal / nonspecific repolarization / significant ST depression0 / 1 / 2
Age<45 / 45–64 / ≥65 years0 / 1 / 2
Risk factorsNone / 1–2 / ≥3 or known atherosclerotic disease0 / 1 / 2
Troponin≤URL / >1 to <3× URL / ≥3× URL0 / 1 / 2

HEART score interpretation

ScoreRisk category
0–3Low
4–6Intermediate
7–10High

The score category is not a standalone disposition decision. Troponin timing, ECG findings, clinical stability, known CAD, alternative diagnoses, and the overall clinical assessment remain essential.

Clinical use and limitations

Pathway considerations

  • Low-risk classification requires a low HEART score and negative initial and serial troponin results below the assay-specific 99th percentile.
  • Use an institutionally validated sampling interval and assay-specific hs-cTn algorithm.
  • New ST elevation, hemodynamic instability, ongoing clinical concern, or a suspected alternative emergency requires assessment outside this low-risk pathway.
  • Known CAD is flagged as a conservative exclusion from the early-discharge suggestion in this implementation.
  • A negative pathway assessment does not exclude every cause of chest pain or replace clinical judgement.

Scope

Designed as an educational clinical decision-support aid for adult emergency-department patients with suspected ACS after immediate STEMI and other emergency conditions have been considered. It is not intended for pediatric patients or as a substitute for local ACS protocols.

References

Mahler SA, Riley RF, Hiestand BC, et al.The HEART Pathway Randomized Trial: Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge. Circ Cardiovasc Qual Outcomes. 2015;8(2):195–203. DOI: 10.1161/CIRCOUTCOMES.114.001384
Backus BE, Six AJ, Kelder JC, et al.A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013;168(3):2153–2158. DOI: 10.1016/j.ijcard.2013.01.255
Januzzi JL Jr, Mahler SA, Christenson RH, et al.Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(9):1059–1077. DOI: 10.1016/j.jacc.2018.12.046
Gulati M, Levy PD, Mukherjee D, et al.2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain. Circulation. 2021;144:e368–e454. DOI: 10.1161/CIR.0000000000001029
Amsterdam EA, Wenger NK, Brindis RG, et al.2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. Circulation. 2014;130:e344–e426. DOI: 10.1161/CIR.0000000000000134
Clinical disclaimer: This calculator supports structured risk assessment and is not a diagnostic test or an autonomous discharge recommendation. Do not use it to delay emergency treatment. Patients with suspected STEMI, hemodynamic instability, persistent/recurrent ischemic symptoms, elevated or changing troponin, ischemic ECG changes, or another potentially life-threatening diagnosis require urgent clinician-led evaluation. Interpret troponin using the specific assay, its 99th percentile URL, serial timing, and locally validated delta criteria.